Poland
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
114.55 |
Jan. 14, 2025 | USD 0.77 | 0.43% |
|
Poland |
|
2 |
78.29 |
Jan. 14, 2025 | USD 2.77 | 1.63% |
|
Poland |
|
3 |
66.70 |
Jan. 14, 2025 | USD 4.92 | 2.76% |
|
Poland |
|
4 |
61.34 |
Jan. 14, 2025 | USD 1.05 | -1.52% |
|
Poland |
|
5 |
24.82 |
Jan. 14, 2025 | USD 204.85 | 1.34% |
|
Poland |
|
6 |
19.75 |
Jan. 14, 2025 | USD 50.91 | 0.74% |
|
Poland |
|
7 |
11.51 |
Jan. 14, 2025 | USD 11.11 | -3.75% |
|
Poland |
|
8 |
3.61 |
Jan. 14, 2025 | USD 2.34 | 1.69% |
|
Poland |
|
9 |
1.53 |
Jan. 14, 2025 | USD 1.01 | 1.23% |
|
Poland |
|
10 |
-1.46 |
Jan. 14, 2025 | USD 3.73 | -0.03% |
|
Poland |
|
11 |
-2.75 |
Jan. 14, 2025 | USD 10.54 | 0.97% |
|
Poland |
|
12 |
-3.14 |
Jan. 14, 2025 | USD 0.71 | 0.06% |
|
Poland |
|
13 |
-7.70 |
Jan. 14, 2025 | USD 7.78 | -9.75% |
|
Poland |
|
14 |
-8.09 |
Jan. 14, 2025 | USD 2.23 | 1.07% |
|
Poland |
|
15 |
-9.31 |
Jan. 14, 2025 | USD 1.85 | -0.17% |
|
Poland |
|
16 |
-10.13 |
Jan. 14, 2025 | USD 1.74 | 1.31% |
|
Poland |
|
17 |
-11.06 |
Jan. 14, 2025 | USD 0.79 | 1.05% |
|
Poland |
|
18 |
-12.61 |
Jan. 14, 2025 | USD 9.29 | -3.28% |
|
Poland |
|
19 |
-22.95 |
Jan. 14, 2025 | USD 40.10 | -0.57% |
|
Poland |
|
20 |
-23.75 |
Jan. 14, 2025 | USD 12.79 | 0.55% |
|
Poland |
|
21 |
-28.86 |
Jan. 14, 2025 | USD 20.34 | -1.25% |
|
Poland |
|
22 |
-46.01 |
Jan. 14, 2025 | USD 6.09 | -0.44% |
|
Poland |
The Pharmaceuticals company in Poland with the highest Price to Earnings Ratio (P/E) is BIOTON S.A. (Warsaw Stock Exchange: BIO.WA) at 114.55.
The Pharmaceuticals company in Poland with the lowest Price to Earnings Ratio (P/E) is Celon Pharma S.A. (Warsaw Stock Exchange: CLN.WA) at -46.01.
The top 10 Pharmaceuticals companies in Poland by Price to Earnings Ratio (P/E) are BIOTON S.A., BioMaxima S.A., Centrum Medyczne ENEL-MED S.A., Synthaverse S.A., NEUCA S.A., Synektik Spólka Akcyjna, Selvita S.A., Mabion S.A., Pharmena S.A. and Pure Biologics Spólka Akcyjna.
The bottom 10 Pharmaceuticals companies in Poland by Price to Earnings Ratio (P/E) are Celon Pharma S.A., Bioceltix S.A., Mercator Medical S.A., Scope Fluidics S.A., Poltreg S.A., NanoGroup S.A., Genomtec S.A., Medinice S.A., Molecure S.A. and Ryvu Therapeutics S.A..